Filing Details
- Accession Number:
- 0001209191-15-058891
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-02 16:28:40
- Reporting Period:
- 2015-06-30
- Filing Date:
- 2015-07-02
- Accepted Time:
- 2015-07-02 16:28:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505512 | Regulus Therapeutics Inc. | RGLS | Pharmaceutical Preparations (2834) | 264738379 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | 2855 Gazelle Court Carlsbad CA 92010 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-23 | 13,248 | $0.00 | 5,529,553 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2015-06-30 | 13,248 | $10.79 | 5,516,305 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares were acquired pursuant to a transfer without consideration from Stanley Crooke, M.D., Ph.D., a former director of the Board of RGLS, immediately upon an exercise by Dr. Crooke of a stock option pursuant to which he acquired such shares.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.76 to $10.84 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Billionaire Hedge Funds
